Morgan Stanley: Analysts Divided After Q3 Miss

The story at MS this week is a widening gap between what the Street thought the quarter would deliver and what it got, leaving analysts clustered around cautious holds while one high-conviction buyer moved in the opposite direction.

The post-earnings analyst response told an unusually split story. Most brokers trimmed targets after the October 14 print. RBC cut its target from $243 to $195, Wells Fargo moved from $223 to $217, and TD Cowen, Evercore, and Citigroup all pulled targets lower while keeping their ratings unchanged. That cluster of cuts, without downgrades, is the pattern of analysts who still believe in the franchise but are acknowledging the stock got ahead of itself. Against that, UBS analyst Erika Najarian moved in the opposite direction just two days ago, raising her target from $236 to $240 and reiterating Buy, the most recent call on the name. The mean target across the Street sits at $237, implying roughly 27% upside to Tuesday's close of $186.09, though that figure is dragged by a range of targets that spans from $190 at Citi to $240 at UBS.

The bull and bear cases are well defined. Bulls point to the durability of the wealth management platform, which accounted for 45% of Q3 revenues at a 30.4% pre-tax margin, with $9.3 trillion in client assets providing a steady fee base. Trading was more complicated: equities revenues rose 23% year on year, but the stock fell 2.4% the day results landed, and was still flat five days later. The bears argue the firm's earnings remain too sensitive to capital markets cycles. FICC softness, deal-flow risk in a recession scenario, and regulatory uncertainty around the balance sheet are the pressure points most cited. At 13.7 times trailing earnings and 2.5 times book, valuation is not demanding by historical standards, with the PE multiple drifting lower over the past 30 days. The earnings yield factor ranks in the 65th percentile against the broader universe, and the EPS surprise score at the 72nd percentile reflects a track record of beating estimates.

Short interest offers no meaningful signal here. At less than 1% of free float, there is essentially no organised short position. The borrow market is as loose as it gets: availability is near its maximum, and cost to borrow has ticked up slightly over the past month but remains below 0.4%. This is not a stock where positioning mechanics are in play.

Options positioning carries a mild defensive tilt. The put/call ratio is running at 1.47, slightly above its 20-day average of 1.43, though the z-score of 0.41 means the gap from normal is modest. The 52-week range on the PCR stretches from 1.21 to 1.63, so current levels are neither extreme. This is routine hedging, not a sharp shift in sentiment.

The most distinctive structural fact in the ownership register is Mitsubishi UFJ Financial Group's 24.1% stake, held via a Schedule 13D on file since November 2025. MUFG is the dominant holder at close to a quarter of the company and filed an amendment in July of this year. Its most recent insider transaction, logged on October 29, was a disposal of 604,000 shares under a pre-arranged 10b5-1 plan, worth around $111 million. That follows a larger September disposal of 1.34 million shares. Both were plan-driven sales, not discretionary selling, but they reinforce that MUFG has been a consistent seller in the second half of this year. As with all 13D/G disclosures, the stake is as-last-filed and positions can move without further disclosure below the 5% threshold.

On alt data, FDIC call report data for Morgan Stanley's insured bank charters shows total assets rising for nine consecutive quarters to $669.7 billion and total deposits rising for nine straight quarters to $490.6 billion, covering the period through April 2026. ORTEX has not yet been able to test whether this dataset leads the firm's reported figures, so it is background colour rather than a leading indicator of the January print. The next earnings event is January 14, 2027, 71 days away.

What matters between now and then is whether Erika Najarian's constructive call proves early or prescient: the gap between her $240 target and the cluster of cautious $190 to $205 targets captures the core debate about whether wealth management fees and trading momentum can sustain the stock at current levels, or whether it needs a catalyst to close that 27% implied upside.